Phospholipid binding plasma proteins required for antiphospholipid antibody detection--an overview (Q33499192)

27 July 2017

1 reference

title

Phospholipid binding plasma proteins required for antiphospholipid antibody detection--an overview (English)

1 reference

27 July 2017

McIntyre JA

1

1 reference

27 July 2017

Wagenknecht DR

series ordinal

2

1 reference

27 July 2017

Sugi T

series ordinal

3

1 reference

27 July 2017

publication date

1 January 1997

1 reference

American Journal of Reproductive Immunology

27 July 2017

published in

1 reference

27 July 2017

volume

37

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

101-110

1 reference

Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Antiphospholipid antibodies in cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Antiphospholipid antibodies differ in aPL cofactor requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Investigations on beta 2-glycoprotein-I in the rat: isolation from serum and demonstration in lipoprotein density fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Molecular cloning and sequence analysis of the cDNA encoding human apolipoprotein H (beta 2-glycoprotein I)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Investigations on the genetics and population genetics of the beta 2-glycoprotein I polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Structural biology, cellular interactions and pathophysiology of the contact system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

High-molecular weight kininogen. A secreted platelet protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Isolation of a human cDNA for alpha 2-thiol proteinase inhibitor and its identity with low molecular weight kininogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Purification and characterization of α1-thiol proteinase inhibitor and its identity with kinin- and fragment 1·2-free high molecular weight kininogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

High molecular weight kininogen binds to unstimulated platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

High molecular weight kininogen is an inhibitor of platelet calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Human plasma kininogens are identical with alpha-cysteine proteinase inhibitors. Evidence from immunological, enzymological and sequence data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Autoantibodies to kininogen-phosphatidylethanolamine complexes augment thrombin-induced platelet aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

Receptors for high molecular weight kininogen on stimulated washed human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00198.X

10.1111/J.1600-0897.1997.TB00198.X

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference